14 employees
Allermi offers direct delivery of customized prescription allergy medications, designed and formulated by world-class allergists.
2020
$1.3M
from 1 investors over 1 rounds
Allermi raised $1.3M on May 10, 2022
Investors: Lucas Venture Group